133 related articles for article (PubMed ID: 7702054)
21. Changes in Serum Bicarbonate Levels Caused by Acetate-Containing Bicarbonate-Buffered Hemodialysis Solution: An Observational Prospective Cohort Study.
Panesar M; Shah N; Vaqar S; Ivaturi K; Gudleski G; Muscarella M; Lambert J; Su W; Murray B
Ther Apher Dial; 2017 Apr; 21(2):157-165. PubMed ID: 28296160
[TBL] [Abstract][Full Text] [Related]
22. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
23. Lack of effect of vitamin B-6 supplementation on the lipoprotein profile of post-menopausal chronic hemodialysis patients.
Pike S; Prati RC; Cochran C; Gorman MA; Ashby J; Liepa GU
J Am Diet Assoc; 1990 Jul; 90(7):968-72. PubMed ID: 2365939
[TBL] [Abstract][Full Text] [Related]
24. Comparison of lipid profiles in long-term CAPD and hemodialysis patients.
Lee SW; Kwon KH; Kim MJ
Perit Dial Int; 1998; 18(4):435-7. PubMed ID: 10505569
[No Abstract] [Full Text] [Related]
25. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276
[TBL] [Abstract][Full Text] [Related]
26. Effects of acetate during regular hemodialysis.
Scheppach W; Kortmann B; Burghardt W; Keller F; Kasper H; Bahner U; Teschner M; Heidland A
Clin Nephrol; 1988 Jan; 29(1):19-27. PubMed ID: 3383461
[TBL] [Abstract][Full Text] [Related]
27. Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction.
Velez RL; Woodard TD; Henrich WL
Kidney Int; 1984 Jul; 26(1):59-65. PubMed ID: 6482180
[TBL] [Abstract][Full Text] [Related]
28. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
Pennell P; Leclercq B; Delahunty MI; Walters BA
Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
[TBL] [Abstract][Full Text] [Related]
29. A double-blind controlled trial of acetate versus bicarbonate dialysate.
Uldall PR; Kennedy I; Craske H; Porrett E; Aid J; Woods F; Levine D
Proc Clin Dial Transplant Forum; 1980; 10():220-3. PubMed ID: 7050983
[TBL] [Abstract][Full Text] [Related]
30. Effects of pancreas transplantation on distribution and composition of plasma lipoproteins.
Föger B; Königsrainer A; Palos G; Ritsch A; Tröbinger G; Menzel HJ; Lechleitner M; Doblinger A; König P; Utermann G; Margreiter R; Patsch JR
Metabolism; 1996 Jul; 45(7):856-61. PubMed ID: 8692021
[TBL] [Abstract][Full Text] [Related]
31. Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients.
Hirano T; Nohtomi K; Nakanishi N; Watanabe T; Hyodo T; Taira T
Clin Nephrol; 2010 Oct; 74(4):282-7. PubMed ID: 20875380
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular response to hemodialysis: the effects of uremia and dialysate buffer.
Jaraba M; Rodríguez-Benot A; Guerrero R; del Castillo D; Martín-Malo A; Rodríguez M; Aljama P
Kidney Int Suppl; 1998 Dec; 68():S86-91. PubMed ID: 9839290
[TBL] [Abstract][Full Text] [Related]
33. Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients.
Piperi C; Kalofoutis C; Tzivras M; Troupis T; Skenderis A; Kalofoutis A
Mol Cell Biochem; 2004 Oct; 265(1-2):57-61. PubMed ID: 15543934
[TBL] [Abstract][Full Text] [Related]
34. The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.
Smith WB; Gibson S; Newman GE; Hendon KS; Askelson M; Zhao J; Hantash J; Flanagan B; Larkin JW; Usvyat LA; Thadhani RI; Maddux FW
BMC Nephrol; 2017 Aug; 18(1):273. PubMed ID: 28851317
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of acetate and bicarbonate hemodialysis on left ventricular function.
Ruder MA; Alpert MA; Van Stone J; Selmon MR; Kelly DL; Haynie JD; Perkins SK
Kidney Int; 1985 May; 27(5):768-73. PubMed ID: 4021310
[TBL] [Abstract][Full Text] [Related]
36. Ability of non-high-density lipoprotein cholesterol and calculated intermediate-density lipoprotein to identify nontraditional lipoprotein subclass risk factors in dialysis patients.
Belani SS; Goldberg AC; Coyne DW
Am J Kidney Dis; 2004 Feb; 43(2):320-9. PubMed ID: 14750098
[TBL] [Abstract][Full Text] [Related]
37. The effect of replacing acetate with bicarbonate in the dialysate of stable chronic hemodialysis patients.
Van Stone JC; Cook J
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():103-5. PubMed ID: 40219
[No Abstract] [Full Text] [Related]
38. Effects of acetate and bicarbonate dialysate on vascular stability: a prospective multicenter study.
La Greca G; Feriani M; Bragantini L; Petrosino L; Santoro A; Altieri P
Int J Artif Organs; 1987 May; 10(3):157-62. PubMed ID: 3610365
[No Abstract] [Full Text] [Related]
39. Lipoprotein lipid abnormalities in healthy renal transplant recipients: persistence of low HDL2 cholesterol.
Ettinger WH; Bender WL; Goldberg AP; Hazzard WR
Nephron; 1987; 47(1):17-21. PubMed ID: 3306427
[TBL] [Abstract][Full Text] [Related]
40. Effects of dietary acetate and bicarbonate on experimental atherosclerosis in rabbits.
Vreman HJ; Thorning D; Weiner MW
Atherosclerosis; 1980 Feb; 35(2):145-53. PubMed ID: 7352953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
